160 related articles for article (PubMed ID: 37653218)
1. The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics.
Baud O; Lehert P;
Pediatr Res; 2024 Jan; 95(1):251-256. PubMed ID: 37653218
[TBL] [Abstract][Full Text] [Related]
2. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Renolleau C; Toumazi A; Bourmaud A; Benoist JF; Chevenne D; Mohamed D; Alberti C; Biran V; Baud O;
J Pediatr; 2021 Jul; 234():65-70.e3. PubMed ID: 33359303
[TBL] [Abstract][Full Text] [Related]
3. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
[TBL] [Abstract][Full Text] [Related]
5. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive outcomes at age 5 years after prophylactic hydrocortisone in infants born extremely preterm.
Trousson C; Toumazi A; Bourmaud A; Biran V; Baud O
Dev Med Child Neurol; 2023 Jul; 65(7):926-932. PubMed ID: 36417367
[TBL] [Abstract][Full Text] [Related]
8. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
[TBL] [Abstract][Full Text] [Related]
9. Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Héneau A; Guimiot F; Mohamed D; Rideau Batista Novais A; Alberti C; Baud O;
Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29348196
[TBL] [Abstract][Full Text] [Related]
10. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
11. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
12. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
13. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
[TBL] [Abstract][Full Text] [Related]
14. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
Trials; 2023 May; 24(1):320. PubMed ID: 37161488
[TBL] [Abstract][Full Text] [Related]
15. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
Morris IP; Goel N; Chakraborty M
Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162
[TBL] [Abstract][Full Text] [Related]
17. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
18. Survival without Bronchopulmonary Dysplasia of Extremely Preterm Infants: A Predictive Model at Birth.
Baud O; Laughon M; Lehert P
Neonatology; 2021; 118(4):385-393. PubMed ID: 34004607
[TBL] [Abstract][Full Text] [Related]
19. Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Jensen EA; Dysart KC; Gantz MG; Carper B; Higgins RD; Keszler M; Laughon MM; Poindexter BB; Stoll BJ; Walsh MC; Schmidt B;
J Pediatr; 2017 Jul; 186():34-40.e2. PubMed ID: 28258737
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality.
Alison M; Tilea B; Toumazi A; Biran V; Mohamed D; Alberti C; Bourmaud A; Baud O;
Arch Dis Child Fetal Neonatal Ed; 2020 Sep; 105(5):520-525. PubMed ID: 31980445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
